Continuing anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of inflammatory bowel disease (IBD) in pregnant women and fewer ...

The US Preventive Services Task Force issued a draft statement earlier this week that recommends screening asymptomatic pregnant women at 24 weeks for gestational diabetes, based on what it says is ...

Infants born before 24 weeks have survival chances below 50 percent, and about 40 percent of those who survive face long-term complications. By 24 weeks, however, the survival rate improves ...